Skip to main content
. 2023 Nov 12;15(11):2620. doi: 10.3390/pharmaceutics15112620

Table 3.

Drug-loaded vesicular system currently in clinical trial.

Vesicular System Payload Phase of Study Clinical Trial Identifier Sponsor
Liposome Irinotecan and Bevacizumab I NCT05854498 University of Wisconsin
(Madison, WI, USA)
Irinotecan-based FOLFIRI combined with Bevacizumab II NCT05969899 Fudan University (Shanghai, China)
Fluorouracil and Irinotecan and Leucovorin I, II NCT03337087 Academic and Community Cancer Research United (Rochester, MN, USA)
Polymeric nanoparticle Cetuximab I NCT03774680 Al-Azhar University
(Cairo, Egypt)